Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10059220HBVENSG00000091513.16protein_codingTFNoNo7018A0PJA6
P02787
Q06AH7
TVIS10059216HBVENSG00000091513.16protein_codingTFNoNo7018A0PJA6
P02787
Q06AH7
TVIS10059221HBVENSG00000091513.16protein_codingTFNoNo7018A0PJA6
P02787
Q06AH7
TVIS10060169HBVENSG00000091513.16protein_codingTFNoNo7018A0PJA6
P02787
Q06AH7
TVIS10060578HBVENSG00000091513.16protein_codingTFNoNo7018A0PJA6
P02787
Q06AH7
TVIS10060581HBVENSG00000091513.16protein_codingTFNoNo7018A0PJA6
P02787
Q06AH7
TVIS10060580HBVENSG00000091513.16protein_codingTFNoNo7018A0PJA6
P02787
Q06AH7
TVIS10059215HBVENSG00000091513.16protein_codingTFNoNo7018A0PJA6
P02787
Q06AH7
TVIS10059223HBVENSG00000091513.16protein_codingTFNoNo7018A0PJA6
P02787
Q06AH7
TVIS10060579HBVENSG00000091513.16protein_codingTFNoNo7018A0PJA6
P02787
Q06AH7
TCGA Plot Options
Drug Information
GeneTF
DrugBank IDDB00515
Drug NameCisplatin
Target IDBE0000510
UniProt IDP02787
Regulation Type
PubMed IDs16773208
CitationsKhalaila I, Bergamo A, Bussy F, Sava G, Dyson PJ: The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapy. Int J Oncol. 2006 Jul;29(1):261-8.
GroupsApproved
Direct ClassificationTransition metal chlorides
SMILES[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H]
Pathways
PharmGKBPA449014
ChEMBLCHEMBL11359